Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 2/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13630691 | 0.83 | — | — | |
| SCHEMBL2876329 | 0.81 | NR1I2 (0.37) | NR1I2OPRM1 | |
| SCHEMBL2876332 | 0.81 | NR1I2 (0.37) | NR1I2OPRM1 | |
| SCHEMBL14048965 | 0.81 | OPRM1 (0.36) | NR1I2OPRM1CHRM2CHRM3 | |
| SCHEMBL13852269 | 0.77 | — | — | |
| SCHEMBL13630694 | 0.73 | CYP2E1 (0.33) | NR1I2 | |
| SCHEMBL2432492 | 0.73 | NR1I2 (0.36) | NR1I2 | |
| SCHEMBL2432488 | 0.73 | NR1I2 (0.36) | NR1I2 | |
| SCHEMBL13630800 | 0.72 | ALDH1A1 (0.41) | — | |
| SCHEMBL14136984 | 0.72 | POLB (0.40) | OPRM1CHRM2CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080269481-A1 | Compounds and methods for the treatment or prevention of Flavivirus infections | VIROCHEM PHARMA INC. (CA) | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269481-A1 | Compounds and methods for the treatment or prevention of Flavivirus infections | ZC3HAV1, ZYX, ZFX | NR1I2 1393/4885OPRM1 4348/4885OPRD1 4221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.